Skip to content
PolarisQB
  • Why Quantum
    • Quantum Computing Today
    • Quantum vs. Traditional Screening
    • Quantum Computing vs. AI
  • QuADD Solutions
    • Hits & Leads
    • Joint Development
    • Pipeline
    • Platform
  • Who We Serve
    • Pharma
    • Biotech
    • Agriculture
    • CROs
  • Resources
    • Blog
    • Whitepapers
    • Webinars
    • Publications
  • Company
    • About Us
    • Customers
    • Partners
    • News
    • Team
  • Contact Us
PolarisQB Logo
  • Why Quantum
    • Quantum Computing Today
    • Quantum vs. Traditional Screening
    • Quantum Computing vs. AI
  • QuADD Solutions
    • Hits & Leads
    • Joint Development
    • Pipeline
    • Platform
  • Who We Serve
    • Pharma
    • Biotech
    • Agriculture
    • CROs
  • Resources
    • Blog
    • Whitepapers
    • Webinars
    • Publications
  • Company
    • About Us
    • Customers
    • Partners
    • News
    • Team
  • Contact Us

Will Simpson

  • PolarisQB Announces the Addition of Board Member Anat Naschitz
    May 7th, 2024· 2.5 min·
    PolarisQB Announces the Addition of Board Member Anat Naschitz

    POLARISqb, a company revolutionizing drug design by joining quantum computing

  • Reconnecting with Partners at JPM
    February 12th, 2024· 2.8 min·
    Reconnecting with Partners at JPM

    JPM week in San Francisco is always a busy time

  • PolarisQB and Scientist.com Partner to Offer Online Access to Quantum-Aided Drug Design, the first Quantum-Enabled Drug Discovery Platform
    January 16th, 2024· 2 min·
    PolarisQB and Scientist.com Partner to Offer Online Access to Quantum-Aided Drug Design, the first Quantum-Enabled Drug Discovery Platform

    POLARISqb, the first company to build quantum-enabled molecular optimization tools

  • Quantum-Aided Drug Design from POLARISqb Demonstrates Best-in-Class Capabilities
    November 14th, 2023· 1.2 min·
    Quantum-Aided Drug Design from POLARISqb Demonstrates Best-in-Class Capabilities

    Polaris Quantum Biotech (PolarisQB), the leader in quantum computing-based drug

  • PolarisQB Receives DARPA IMPAQT Funding to Advance Quantum Computing for Drug Design
    October 17th, 2023· 2.8 min·
    PolarisQB Receives DARPA IMPAQT Funding to Advance Quantum Computing for Drug Design

    The Defense Advanced Research Project Agency (DARPA) awarded POLARISqb a

  • PolarisQB and Syntekabio sign MOU for Collaborative AI and Quantum-powered Drug Development Service
    September 12th, 2023· 2.3 min·
    PolarisQB and Syntekabio sign MOU for Collaborative AI and Quantum-powered Drug Development Service

    PolarisQB, the first company in the world to develop a drug

  • A Very Brief History of Very Large Numbers
    July 17th, 2023· 3.4 min·
    A Very Brief History of Very Large Numbers

    What is the largest number of which you can conceive? This question

  • White Paper on QuADD shows Marked Advantage Versus Conventional Library Builds
    June 29th, 2023· 1.9 min·
    White Paper on QuADD shows Marked Advantage Versus Conventional Library Builds

    Polaris Quantum Biotech (PolarisQB) leverages quantum computing to accelerate drug discovery, revolutionizing

  • PolarisQB New SaaS, Quantum-Aided Drug Design (QuADD) Demonstrates Advantage Versus Traditional Library Builds
    June 7th, 2023· 2.4 min·
    PolarisQB New SaaS, Quantum-Aided Drug Design (QuADD) Demonstrates Advantage Versus Traditional Library Builds

    At Polaris Quantum Biotech, we’re leveraging quantum computing to accelerate drug discovery.

  • PolarisQB Announces Quantum SaaS: Quantum Aided Drug Design (QuADD)
    June 1st, 2023· 2.2 min·
    PolarisQB Announces Quantum SaaS: Quantum Aided Drug Design (QuADD)

    PolarisQB, an industry leader in accelerating drug discovery using quantum computing,

Previous123Next
Search
Recent Posts
  • An Investigation of Allostery in Epidermal Growth Factor Receptor Using Sextant with Dynamics Simulations to Expand an Apo Site February 28, 2025
  • Combinatorial Optimization vs. Physical Simulation January 19, 2025
  • Quantum-Aided Drug Design for Inhibiting Protein-Protein Interactions for Emerging Threats January 12, 2025
Categories
  • Blog (14)
  • News (43)

Why Quantum

Quantum Computing Today
Quantum vs. Traditional Screening
Quantum vs. AI

QuADD Solutions

Hits & Leads
Joint Development
Pipeline
Platform

Who We Serve

Pharma
Biotech
Agriculture
CROs

Resources

Blog
Whitepapers
Webinars
Publications

Company

About Us
Customers
Partners
News
Team
Contact

212 W Main St
Suite 200 PMB 205
Durham, NC 27701

info@polarisqb.com
919.200.0592

© 2025 All Rights Reserved | Privacy Policy | Terms of Use

Page load link
Go to Top